Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
30 USD | +3.59% | -0.87% | +4.20% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.20% | 1.59B | |
+7.22% | 72.81B | |
+12.72% | 9.13B | |
-11.75% | 5.13B | |
+59.61% | 4.99B | |
+2.62% | 3.9B | |
-17.54% | 2.48B | |
+21.35% | 2.42B | |
-27.82% | 2.32B | |
+25.13% | 2.17B |
- Stock Market
- Equities
- SUPN Stock
- News Supernus Pharmaceuticals, Inc.
- Supernus Pharmaceuticals : to Buy Adamas Pharmaceuticals for up to $9.10 per Share in Cash, Contingent Value Rights Deal